genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2013
Drug side effects
News
Treatment Options for Side Effects: Today and Tomorrow
Drug Discovery
Oxford Pharmascience Wins Option for 53 More UCL Compounds
News
FDA Halts Amgen Sensipar Trials After Patient Dies
Cancer
Immune Pharmaceuticals Merges with EpiCept
Infectious Diseases
FDA: HIV Numbers Drove Truvada Decision
Insights
Search for New Analgesics Worth the Pain Given Side Effects of Opioids
Cancer
Paladin Obtains License to All ProStrakan Products in Emerging Territories
Cancer
Tesaro Secures Opko’s Late-Stage Anti-Emetic Rolapitant
News
Adolor Awarded $0.3M by MJFF to Develop PD Drugs for Levodopa-Induced Dyskinesia
News
Sosei Out-Licenses Malaria IP to Treague
1
2
3
4
Page 3 of 4
Scroll Up
Scroll Up
